Skip to main content
William Harless, MD, Oncology, Naperville, IL, Waldo County General Hospital

WilliamWHarlessMDPhD

Oncology Naperville, IL

Hematologic Oncology, Hospice & Palliative

Medical Oncology and Hematology CEO, ENCYT Technologies

Dr. Harless is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Harless' full profile

Already have an account?

Education & Training

  • West Virginia University
    West Virginia UniversityFellowship, Hematology and Medical Oncology, 2004 - 2006
  • Carle Foundation Hospital
    Carle Foundation HospitalResidency, Internal Medicine, 1997 - 2000
  • University of Texas Medical Branch School of Medicine
    University of Texas Medical Branch School of MedicineClass of 1996
  • University of Texas
    University of Texas PhD, Biological Sciences, 1988 - 1994

Certifications & Licensure

  • CT State Medical License
    CT State Medical License Current
  • AL State Medical License
    AL State Medical License Current
  • WV State Medical License
    WV State Medical License 2004 - 2024
  • VT State Medical License
    VT State Medical License 2022 - 2024
  • ME State Medical License
    ME State Medical License 2019 - 2024
  • MI State Medical License
    MI State Medical License 2020 - 2023
  • IA State Medical License
    IA State Medical License Active through 2022
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Pdq Hematology by William F Kern Md 2002 04 15
    Pdq Hematology by William F Kern Md 2002 04 15June 28th, 2020
  • Cape Breton Could Become an Important Place in the Attack on Pancreatic Cancer: Encyt Technologies Awaits Health Canada Approval
    Cape Breton Could Become an Important Place in the Attack on Pancreatic Cancer: Encyt Technologies Awaits Health Canada ApprovalSeptember 5th, 2019

Hospital Affiliations